Osteosarcopenia in Finland: prevalence and associated factors.


Journal

Archives of osteoporosis
ISSN: 1862-3514
Titre abrégé: Arch Osteoporos
Pays: England
ID NLM: 101318988

Informations de publication

Date de publication:
30 Aug 2024
Historique:
received: 31 01 2024
accepted: 12 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 30 8 2024
Statut: epublish

Résumé

This cross-sectional study investigated osteosarcopenia prevalence and its correlates among 2142 adults aged 55 and older in Finland. Findings show 3.9% had osteosarcopenia, while 13.8% and 11.1% had probable sarcopenia only or osteoporosis only, respectively. Osteosarcopenia was associated with low BMI, impaired mobility, ADL limitations and depression. Sarcopenia appeared to drive these associations more than osteoporosis. Osteosarcopenia may be a risk factor for functional decline, hospitalization, and institutionalization, warranting further research. Osteosarcopenia is a disorder consisting of concurrent osteoporosis and sarcopenia. This cross-sectional study using nationally representative data from Finland in 2000 aimed to determine the prevalence of osteosarcopenia in Finland. In addition, associations of sociodemographic, lifestyle, anthropometric, physical and mental function indicators, chronic conditions and various biomarkers with osteosarcopenia were examined. The study included 2142 subjects aged 55 and over (mean age 68.0 years, SD 9.0). Probable sarcopenia was defined as grip strength < 27 kg for men and < 16 kg for women. Osteoporosis was defined as either ultrasound-based bone density measurement of T < -2.5, or self-reported, pre-existing diagnosis of osteoporosis. Participants were categorized into 4 groups: no sarcopenia and no osteoporosis, probable sarcopenia only, osteoporosis only, and osteosarcopenia. Information on sociodemographic, lifestyle, anthropometric, physical and mental function indicators, chronic conditions and various biomarkers were collected via structured interview, questionnaires, clinical examination, and blood and urine samples. The prevalence of probable sarcopenia, osteoporosis and osteosarcopenia was 13.8%, 11.1%, and 3.9%, respectively. Osteosarcopenia was associated with low BMI, slow gait speed, impaired mobility, impaired ability in the activities of daily living and depression. Of the two components, probable sarcopenia appeared to contribute to these associations more than osteoporosis. According to representative population-based study, about every fifth person with probable sarcopenia also has osteoporosis. Mobility and ADL limitations were more common among people with osteosarcopenia than those with osteoporosis or probable sarcopenia alone. Future studies are needed to examine osteosarcopenia as an independent risk factor for functional decline, hospitalization, and institutionalization.

Identifiants

pubmed: 39212839
doi: 10.1007/s11657-024-01439-7
pii: 10.1007/s11657-024-01439-7
pmc: PMC11364597
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

80

Informations de copyright

© 2024. The Author(s).

Références

World Health Organ Tech Rep Ser. 1994;843:1-129
pubmed: 7941614
Osteoporos Int. 2021 Nov;32(11):2173-2183
pubmed: 33877382
Chron Respir Dis. 2017 Feb;14(1):85-99
pubmed: 27923981
J Gerontol A Biol Sci Med Sci. 2018 Aug 10;73(9):1199-1204
pubmed: 29300839
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Scand J Med Sci Sports. 2016 Jan;26(1):93-100
pubmed: 25559167
Front Cell Dev Biol. 2020 Dec 10;8:585644
pubmed: 33363144
Eur Geriatr Med. 2018 Aug;9(4):419-434
pubmed: 34674498
Bone. 2003 May;32(5):571-8
pubmed: 12753874
Z Gerontol Geriatr. 2019 Nov;52(7):688-693
pubmed: 31049683
Age Ageing. 2016 Sep;45(5):602-8
pubmed: 27126327
Br J Hosp Med (Lond). 2018 May 2;79(5):253-258
pubmed: 29727228
Eur Geriatr Med. 2023 Apr;14(2):225-228
pubmed: 36869279
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):28-36
pubmed: 27066316
Osteoporos Int. 2015 Dec;26(12):2793-802
pubmed: 26068298
J Clin Densitom. 2009 Oct-Dec;12(4):413-6
pubmed: 19733110
J Clin Epidemiol. 2006 Sep;59(9):994-1001
pubmed: 16895824
J Am Med Dir Assoc. 2016 Dec 1;17(12):1164.e7-1164.e15
pubmed: 27816484
PLoS One. 2020 Aug 7;15(8):e0237454
pubmed: 32764814
Biomolecules. 2020 Mar 10;10(3):
pubmed: 32164381
Diabetes Care. 2017 Dec;40(12):1710-1718
pubmed: 28986505
Public Health Nutr. 2010 Jun;13(6A):915-9
pubmed: 20513260
Scand J Public Health. 2006;34(4):378-86
pubmed: 16861188
Age Ageing. 2021 Nov 10;50(6):1906-1913
pubmed: 34537833
Bone. 2000 Nov;27(5):585-90
pubmed: 11062343
J Am Med Dir Assoc. 2015 Apr;16(4):290-5
pubmed: 25512216

Auteurs

Matias Blomqvist (M)

University of Turku, Turun Yliopisto, Turku, Finland. maerbl@utu.fi.
Department of Geriatric Medicine, University of Turku, Turku, Finland. maerbl@utu.fi.

Maria Nuotio (M)

University of Turku, Turun Yliopisto, Turku, Finland.
Department of Geriatric Medicine, Turku University Hospital and University of Turku, Turku, Finland.

Katri Sääksjärvi (K)

University of Turku, Turun Yliopisto, Turku, Finland.
Population Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.

Seppo Koskinen (S)

University of Turku, Turun Yliopisto, Turku, Finland.
Population Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.

Sari Stenholm (S)

University of Turku, Turun Yliopisto, Turku, Finland.
Department of Public Health, University of Turku and Turku University Hospital, Turku, Finland.
Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.
Research Services, Turku University Hospital and University of Turku, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH